Skip to content

Effect of Triple Pre-rehabilitation on Radiotherapy for Head and Neck Cancer Patients

Effect of Triple Pre-rehabilitation on Radiotherapy for Head and Neck Cancer Patients: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05594069
Enrollment
87
Registered
2022-10-26
Start date
2022-11-24
Completion date
2023-10-30
Last updated
2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer, Radiotherapy, Triple Pre-rehabilitation

Brief summary

To evaluate the intervention effect of triple pre-rehabilitation on head and neck cancer patients with radiotherapy, and process evaluation to further optimize the intervention program. The pre-rehabilitation intervention was develped previously based on the process of evidence-based-nursing, including interventions of nurtrtion, exercise, and psychology.

Interventions

OTHERtriple pre-rehabilitation

The triple intervention consisted of exercise, nutrition and psychology. Based on the intervention framework, face-to-face intervention adjustment and intensive intervention measures were carried out from the time of enrollment (T0). Combined with weekly telephone follow-up during the intervention, the intervention content formulated face-to-face last time was reviewed, reinforcement behaviors were performed, and questions were answered during the intervention.

OTHERtriple rehabilitation

The triple intervention consisted of exercise, nutrition and psychology. Based on the intervention framework, face-to-face intervention adjustment and intensive intervention measures were carried out at the time of the beginning of radiotherapy (T1), and the middle stage of radiotherapy (T2). Combined with weekly telephone follow-up during the intervention, the intervention content formulated face-to-face last time was reviewed, reinforcement behaviors were performed, and questions were answered during the intervention.

Sponsors

China International Medical Foundation
CollaboratorOTHER
Peking University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* 18≤ age \< 75 years old * The pathological diagnosis of HNC included nasopharyngeal cancer, oral cancer, oropharyngeal cancer, hypopharyngeal cancer, laryngeal cancer, salivary gland cancer; * Plan to receive radiotherapy * Basic communication skills * Volunteer to participate in this study.

Exclusion criteria

* Combined with other malignant tumors * Distant metastasis * Inability to measure body composition, such as metal in the body or inability to stand alone * With contraindications to exercise (such as cardiovascular and cerebrovascular diseases, respiratory diseases, etc) * Complicated with severe liver and kidney function damage * Previous diagnosis of other cancers * pregnant or lactation women.

Design outcomes

Primary

MeasureTime frameDescription
Critical weight lossAbout 6 weeksWeight loss over 5% during radiotherapy

Secondary

MeasureTime frameDescription
Rate of adverse reactions of radiotherapy assessed by CTCAE v5.0About 6 weeksAdverse reactions of radiotherapy
Intake assessed by a simple diet self-assessment tool (SDSAT)About 6 weeksIntake assessed by a simple diet self-assessment tool (SDSAT)
Physical performanceAbout 6 weeksPhysical performance measured by the 4-Meter Walk Test
Body composition measured by Bioelectrical Impedance Analysis (BIA)About 6 weeksBody composition measured by Bioelectrical Impedance Analysis (BIA)
Quality of life of patients assessed by QLQ-C30About 6 weeksQuality of life of patients assessed by QLQ-C30
Number of participants with intervention-related adverse eventsAbout 6 weeksNumber of participants with intervention-related adverse events
Patients in the intervention group were interviewed about the compliance of the studyAbout 6 weeksPatients in the intervention group were interviewed about the compliance of the study
Patients in the intervention group were interviewed about the experience of the studyAbout 6 weeksPatients in the intervention group were interviewed about the experience of the study
Psychological status assessed by hospital anxiety and depression scale (HADS)About 6 weeksPsychological status assessed by hospital anxiety and depression scale (HADS)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026